ABIVAX Société Anonyme (EPA:ABVX)
71.50
+1.20 (1.71%)
Sep 24, 2025, 5:35 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €5.40 billion as of September 24, 2025. Its market cap has increased by 722.60% in one year.
Market Cap
5.40B
Enterprise Value
5.44B
Revenue
6.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€71.50
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 5.40B, an increase of 2,573.38%. That is a compound annual growth rate of 37.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 24, 2025 | 5.40B | 1,162.05% |
Dec 31, 2024 | 428.15M | -30.40% |
Dec 29, 2023 | 615.18M | 493.46% |
Dec 30, 2022 | 103.66M | -77.81% |
Dec 31, 2021 | 467.16M | -1.83% |
Dec 31, 2020 | 475.89M | 79.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 126.77B |
Sanofi | 97.62B |
Sartorius Stedim Biotech | 18.21B |
bioMérieux | 13.48B |
Eurofins Scientific SE | 11.13B |
Ipsen | 9.54B |
Virbac | 2.64B |
emeis Société anonyme | 1.96B |